Abiopharma

🔍 OGNALL ANDREW H (Executive)

Company: COLUMBIA BANKING SYSTEM, INC. (COLB)

Report Date: 2026-03-13

Detailed Transactions and Holdings:

• Acquired 2,381 shares of Common Stock at $26.23 per share (Direct)
  Date: 2026-03-13 | Code: M | equity_swap_involved: 0 | shares_owned_after: 75,083.00 | transaction_form_type: 4
• Sold 951 shares of Common Stock at $26.23 per share (Direct)
  Date: 2026-03-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 74,132.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-13 | Code: H | nature_of_ownership: by 401(k) | shares_owned_after: 2,635.00
• Sold 2,381 shares of Restricted Stock Unit (Derivative)
  Date: 2026-03-13 | Code: M | equity_swap_involved: 0 | shares_owned_after: 53,026.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Restricted Stock Units convert into common stock on a one-for-one basis. On February 25, 2025, the reporting person was granted 7,142 Restricted Stock Units, which vest in three annual installments beginning on March 13, 2026.